|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print February 20, 2002
Am J Physiol Gastrointest Liver Physiol, 10.1152/ajpgi.00460.2001
Submitted on October 31, 2001
Accepted on February 4, 2002
* To whom correspondence should be addressed. E-mail: bercikp{at}mcmaster.ca.
The association between oral contraceptives, or pregnancy and inflammatory bowel disease is unclear. We investigated whether 17ß-estradiol modulates intestinal inflammation in two models of colitis. Female mice were treated with 17ß-estradiol alone or with tamoxifen, 17
-estradiol or placebo. Dinitrobenzene sulfonic acid (DNB) or dextran sodium sulfate (DSS)-induced colitis were assessed macroscopically, histologically and by myeloperoxidase (MPO) activity. Malondialdehyde and mRNA levels of adhesion molecule ICAM-1, interferon-
(IFN
) and IL-13 were determined. In DNB colitis, 17ß−estradiol, but not 17ß-estradiol plus tamoxifen or 17
-estradiol, reduced macroscopic and histologic scores, MPO activity and malondialdehyde levels. 17ß-Estradiol also decreased the expression of ICAM-1, IFN
and IL-13 mRNA levels compared to placebo. In contrast, 17ß-estradiol increased the macroscopic and histologic scores compared to placebo in mice with DSS colitis. These results demonstrate anti-inflammatory and pro-inflammatory effects of 17ß-estradiol in two different models of experimental colitis. The net modulatory effect most likely reflects a combination of estrogen receptor mediated effects and antioxidant activity and may explain, in part, conflicting results from clinical trials.
This article has been cited by other articles:
![]() |
E F Verdu, P Bercik, M Verma-Gandhu, X-X Huang, P Blennerhassett, W Jackson, Y Mao, L Wang, F Rochat, and S M Collins Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice Gut, February 1, 2006; 55(2): 182 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Motomura, H. Kanbayashi, W. I. Khan, Y. Deng, P. A. Blennerhassett, P. J. Margetts, J. Gauldie, K. Egashira, and S. M. Collins The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-{beta} type II receptor gene transfer Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G143 - G150. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Harnish, L. M. Albert, Y. Leathurby, A. M. Eckert, A. Ciarletta, M. Kasaian, and J. C. Keith Jr. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol, January 1, 2004; 286(1): G118 - G125. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, Y. Fan, and D. H. Teitelbaum Intraepithelial lymphocyte-derived interferon-gamma evokes enterocyte apoptosis with parenteral nutrition in mice Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G629 - G637. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |